Advisory Council

Monisha supports strategic planning, market shaping, and financing efforts to accelerate the introduction and scale up of innovative global health products and services across priority disease areas. She also leads CII’s work on value-based care which explores patient-centered innovations in measurement, delivery, and payment models that align payers and providers to improve quality of care. Prior to CII, Monisha was a Project Leader at the Boston Consulting Group (BCG) in Washington D.C. She previously worked with the World Bank on a national study on healthcare availability and quality in India. She holds an MPA in International Development (MPA/ID) from the Harvard Kennedy School and BAs in Economics and Public Health from the University of California, Berkeley

Dr. Nana A. Y. Twum-Danso is a public health and preventive medicine physician and a social entrepreneur who is zealous about finding systematic solutions to complex problems. She has more than 15 years of experience in public health policy, strategy, program design, implementation, monitoring, evaluation, and research at local, national and global levels. Nana served as a Commissioner on the Lancet Commission on High Quality Health Systems. Nana was the founder and CEO of MAZA, a social enterprise that provides timely access to health care in rural Ghana. Before founding MAZA, Nana worked as a senior program officer at the Gates Foundation, where she shaped and managed grants to improve maternal and child health outcomes at scale and provided strategic guidance on adolescent health. Prior to that, she led Project Fives Alive!, a nationwide quality improvement initiative to reduce child mortality in Ghana. Nana received her undergraduate and medical education from Harvard University and her public health and preventive medicine training from Emory University.

Sarang’s primary area of research is health care delivery systems with specific focus on investigating the impact of operations decisions on population level health outcomes. Some of the healthcare contexts that he has studied include the influenza vaccine supply chain and the phenomenon of ambulance diversion in the US, HIV early infant diagnosis networks in sub-Saharan Africa, and formal and informal pathways for TB diagnosis in India. Dr. Sarang regularly collaborates with international public health funding and implementation agencies such as the Gates Foundation, Clinton Health Access Initiative, and PATH for his research. Prior to joining the ISB, he was Assistant Professor at the Kellogg School of Management. He obtained a PhD from UCLA Anderson School of Management, MBA from IIM Ahmedabad, and B. Tech. from IIT Bombay.

Dr. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation. Before joining Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. Previously, Mark was Administrator of the Centers for Medicare & Medicaid Services (CMS) and Commissioner of the U.S. Food and Drug Administration (FDA). He obtained joint MD - PhD degrees from Harvard and MIT.

Dr. Shivani Ranchod is a healthcare actuary and academic with 20 years of experience across the health sector. She is a part-time academic at the University of Cape Town, where she was previously the head of Actuarial Science. She is also appointed as a long-term advisor to the Government Technical Advisory Centre (GTAC), a component of National Treasury. Dr Ranchod is Co-Founder and CEO of Percept, a South African multi-disciplinary consultancy to clients who are working towards a healthier, more financially resilient world. She is also Co-Founder of Alignd, a value-based care company in South Africa.

Krishna Reddy, MD, is responsible for the overall development, management, and leadership of the activities of ACCESS Health in India. Krishna is a board-certified cardiologist with a long and distinguished career. He is known internationally as a pioneer in comprehensive primary care, digital health, and integrated care. Prior to joining ACCESS Health, Dr. Reddy was Director and Vice Chairman of CARE Hospitals. Dr. Reddy co-founded CARE Hospital in 1997.

Nicole heads the PharmAccess Foundation, Medical Credit Fund, Health Insurance Fund, and SafeCare. Nicole joined PharmAccess in 2009. She launched SafeCare, PharmAccess’ stepwise certification approach to standardize and improve the quality of healthcare facilities. In 2016, she moved to Kenya where she led the digital innovation agenda of PharmAccess as Director of Quality and Director East Africa. Together with partner organization CarePay, Spieker stood at the forefront of the roll-out of the mobile health exchange platform M-TIBA, which to date has connected over 4.5 million people to healthcare providers. Nicole holds a PhD in Molecular Genetics.

Neo is a physician, epidemiologist and healthcare innovator with over 10 years’ experience in health research (including outcomes), policy and program leadership. She has managed complex collaborations in the government, non-profit and academic sectors, including heading Botswana’s national program for Non-Communicable Diseases (NCDs), directing a multi-site clinical program for an international non-profit, Partners In Health, and serving as a consultant to World Health Organization. Most recently, Neo was a Senior Research Fellow at the University of Oxford’s Nuffield Department of Population Health, where she led multiple funded research projects to design and evaluate healthcare delivery models for NCDs in resource-limited settings. Neo holds an MD from Harvard Medical School and MPH from Harvard School of Public Health.